{
  "main_header": {
    "sid": 1233549,
    "name": "Betta Pharmaceuticals Co., Ltd.",
    "stock_name": "Betta Pharmaceuticals Co., Ltd.",
    "full_name": "Betta Pharmaceuticals Co., Ltd.",
    "name_url": "stocks-analysis/betta-pharmaceuticals-co-",
    "exchange": 46,
    "exchangecode": "SHE",
    "country_id": 12,
    "currency": "CNY",
    "cmp": "47.38",
    "chg": -0.92,
    "chgp": "-1.9%",
    "dir": -1,
    "prev_price": "48.30",
    "mcapval": "27,699.09",
    "mcap": "Large Cap",
    "scripcode": "",
    "symbol": "",
    "ind_name": "Pharmaceuticals & Biotechnology",
    "ind_code": 2305,
    "indexname": "China Shanghai Composite",
    "isin": "CNE100002DD9",
    "curr_date": "Dec 04",
    "curr_time": "",
    "bse_nse_vol": "7.15 M",
    "exc_status": "Active",
    "traded_date": "Dec 04, 2025",
    "traded_date_str": "2025 12 04",
    "score": "",
    "scoreText": "",
    "Live": 0,
    "market_time": 0,
    "is_blur": 1,
    "is_blur_class": "blur-registerF-score-header",
    "is_blur_url": "https://www.marketsmojo.com/mojofeed/register?redirect=/stocks-analysis/betta-pharmaceuticals-co--1233549-46&utm_source=Spage_Header_Score",
    "mojoone": {
      "ismore": 0
    }
  },
  "news": {
    "results": [
      {
        "title": "Betta Pharmaceuticals Hits Day Low of CNY 56.56 Amid Price Pressure",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/betta-pharmaceuticals-hits-day-low-of-cny-5656-amid-price-pressure-3626804",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/10/BettaPharmaceut_priceRelatedfactors_3626804.png",
        "date": "2025-10-16 19:19:51",
        "description": "Betta Pharmaceuticals Co., Ltd. faced notable market activity on October 15, 2025, with a significant decline in stock value. Despite recent short-term challenges, the company has shown strong annual performance, outperforming the China Shanghai Composite. Financial metrics reveal a market capitalization of CNY 27,699 million and a price-to-earnings ratio of 72.00."
      },
      {
        "title": "Betta Pharmaceuticals Hits Day Low of CNY 56.08 Amid Price Pressure",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/betta-pharmaceuticals-hits-day-low-of-cny-5608-amid-price-pressure-3622985",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/10/BettaPharmaceut_priceRelatedfactors_3622985.png",
        "date": "2025-10-15 17:51:03",
        "description": "Betta Pharmaceuticals Co., Ltd. faced a challenging trading day on October 14, 2025, with a notable stock decline. Despite recent downturns, the company has achieved a strong annual return and maintains a significant market capitalization, alongside a high price-to-earnings ratio and a modest dividend yield."
      },
      {
        "title": "Betta Pharmaceuticals Hits Day Low of CNY 65.03 Amid Price Pressure",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/betta-pharmaceuticals-hits-day-low-of-cny-6503-amid-price-pressure-3620356",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/10/BettaPharmaceut_priceRelatedfactors_3620356.png",
        "date": "2025-10-14 19:49:37",
        "description": "Betta Pharmaceuticals Co., Ltd. saw a significant decline in its stock today, contrasting with the broader market's performance. Despite recent losses, the company has demonstrated strong long-term growth, with notable increases in stock value over the past year and three years, alongside key financial metrics reflecting its industry standing."
      },
      {
        "title": "Betta Pharmaceuticals Hits Day Low of CNY 65.32 Amid Price Pressure",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/betta-pharmaceuticals-hits-day-low-of-cny-6532-amid-price-pressure-3586195",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/10/BettaPharmaceut_priceRelatedfactors_3586195.png",
        "date": "2025-10-01 17:12:33",
        "description": "Betta Pharmaceuticals Co., Ltd. saw a decline in its stock today, contrasting with a gain in the China Shanghai Composite. Despite recent fluctuations, the company has achieved significant annual growth and maintains a strong market capitalization, price-to-earnings ratio, and return on equity, reflecting its long-term resilience."
      }
    ],
    "total": 4,
    "sid": "1233549",
    "stock_news_url": "https://www.marketsmojo.com/news/betta-pharmaceuticals-co--1233549"
  },
  "announcements": "",
  "corporate_actions": {
    "msg": "No corporate action Found"
  }
}

News and Views

Betta Pharmaceuticals Hits Day Low of CNY 56.56 Amid Price Pressure

2025-10-16 19:19:51

Betta Pharmaceuticals Co., Ltd. faced notable market activity on October 15, 2025, with a significant decline in stock value. Despite recent short-term challenges, the company has shown strong annual performance, outperforming the China Shanghai Composite. Financial metrics reveal a market capitalization of CNY 27,699 million and a price-to-earnings ratio of 72.00.

Read More

Betta Pharmaceuticals Hits Day Low of CNY 56.08 Amid Price Pressure

2025-10-15 17:51:03

Betta Pharmaceuticals Co., Ltd. faced a challenging trading day on October 14, 2025, with a notable stock decline. Despite recent downturns, the company has achieved a strong annual return and maintains a significant market capitalization, alongside a high price-to-earnings ratio and a modest dividend yield.

Read More

Betta Pharmaceuticals Hits Day Low of CNY 65.03 Amid Price Pressure

2025-10-14 19:49:37

Betta Pharmaceuticals Co., Ltd. saw a significant decline in its stock today, contrasting with the broader market's performance. Despite recent losses, the company has demonstrated strong long-term growth, with notable increases in stock value over the past year and three years, alongside key financial metrics reflecting its industry standing.

Read More

Betta Pharmaceuticals Hits Day Low of CNY 65.32 Amid Price Pressure

2025-10-01 17:12:33

Betta Pharmaceuticals Co., Ltd. saw a decline in its stock today, contrasting with a gain in the China Shanghai Composite. Despite recent fluctuations, the company has achieved significant annual growth and maintains a strong market capitalization, price-to-earnings ratio, and return on equity, reflecting its long-term resilience.

Read More

View All News